Unmodulated 5 Kilohertz Currents Versus TENS: Effect on Pain Thresholds, Tactile Threshold, and Nerve Conduction

July 3, 2017 updated by: University of Castilla-La Mancha

Unmodulated 5 Kilohertz Alternating Currents Versus TENS: Effect on Mechanical and Thermal Pain Thresholds, Tactile Threshold, and Peripheral Nerve Conduction in Humans.

The purpose of this study is to determine whether the transcutaneous application of unmodulated 5 Kilohertz (KHz) alternating currents are effective in decreasing the thermal and mechanical experimental pain and cause changes in peripheral nerve conduction. Moreover evidence whether the effect and comfort of this current is greater than Conventional TENS (Transcutaneous Electrical Nerve Stimulation) commonly used for the treatment of clinical pain.

Study Overview

Status

Completed

Conditions

Detailed Description

In the last years several animal experimental studies have evidenced that high frequency unmodulated currents about 5 KHz can cause a peripheral nerve block. However electric currents with these high frequencies that are usually used for the treatment of pain in humans are interrupted or modulated (i.e. interferential currents)

This evidences in animals could have application in pain treatment, characterized by overactive nervous system. For this reason it was decided to compare the effects on experimental pain and peripheral nerve conduction of this new electric current versus sham stimulation and TENS (Transcutaneous Electrical Nerve Stimulation).

The scientific literature on transcutaneous electrical stimulation in humans and changes in nerve conduction and / or somatosensory thresholds focuses mainly on TENS (Transcutaneous Electrical Nerve Stimulation). Therefore TENS is a good reference standard to compare the effect of this new currents.

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants will be volunteer healthy students of Physiotherapy, University of Castilla - La Mancha, older than 18 years.

Exclusion Criteria:

  • Neuromuscular disease.
  • Epilepsy.
  • Trauma, surgery or pain affecting the upper limb, shoulder girdle or cervical area.
  • Osteosynthesis material in the upper limb.
  • Diabetes.
  • Cancer.
  • Cardiovascular disease.
  • Pacemaker or other implanted electrical device.
  • Take any drug (NSAIDs, corticosteroids, antidepressants, analgesics, antiepileptics, ...) during the study and in the previous 7 days.
  • Presence of tattoos or other external agent introduced into the treatment or assessment area.
  • Pregnancy.
  • Sensitivity disturbance in upper limb.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 5 KHz
Transcutaneous application of 5 KHz current over the course of the superficial radial nerve in the right forearm for a 20 minutes session. The intensity of the current will increase until participants report a "strong but comfortable" sensation, just below motor threshold.
5 KHz transcutaneous electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)
Experimental: TENS
Transcutaneous application of Conventional TENS current over the course of the superficial radial nerve in the right forearm for a 20 minutes session. The intensity of the current will increase until participants report a "strong but comfortable" sensation, just below motor threshold. Currents parameters are frequency 110 Hz and pulse width 200 microseconds
TENS transcutaneous electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)
Sham Comparator: Sham Stimulation
Electrodes are placed over the course of the superficial radial nerve in the right forearm for a 20 minutes in the same manner as experimental groups, but will be applied a sham electrical stimulation increasing the current intensity of an unconnected channel.
Sham transcutaneous electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mechanical Pain Threshold During Treatment
Time Frame: during treatment at 15 min
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
during treatment at 15 min
Thermal Pain Threshold During Treatment
Time Frame: during treatment at 15 min.
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
during treatment at 15 min.
Nerve Conduction Latency Immediately After Treatment
Time Frame: immediately after treatment at 20 min.
The compound action potential latencies will be measured and will be expressed in ms.
immediately after treatment at 20 min.
Tactile Threshold During Treatment
Time Frame: during treatment at 15 min.
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
during treatment at 15 min.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Habituation to Electrical Stimulation
Time Frame: Start treatment session (1 min), end treatment session (20 min)
The habituation to electrical stimulation along experimental session will be measured by recording the difference on current intensity (mA) at the start of the treatment session (1 min) and end of the same (20 min)
Start treatment session (1 min), end treatment session (20 min)
Perception Current Comfortability
Time Frame: At the end of the third experimental session, 3 days
Participants will choose the current treatment that has found more comfortable
At the end of the third experimental session, 3 days
Change Current Density (mA/cm2)
Time Frame: at 1 min. treatment session, at 20 min. treatment session
Change in current density (mA/cm2), it will be recorded at 1 min. start of the treatment session and at 20 min of the same.
at 1 min. treatment session, at 20 min. treatment session
Change From Baseline in Nerve Conduction Amplitude ( µV)
Time Frame: Baseline,immediately after treatment at 20 min..
The compound action potential amplitudes ( µV) will be measured.
Baseline,immediately after treatment at 20 min..
Baseline Mechanical Pain Threshold
Time Frame: Baseline at 0 min.
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
Baseline at 0 min.
Mechanical Pain Threshold Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
at 20 min. post-treatment
Mechanical Pain Threshold Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton.
at 40 min. post-treatment
Baseline Thermal Pain Threshold
Time Frame: Baseline at 0 min.
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
Baseline at 0 min.
Thermal Pain Threshold Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
at 20 min. post-treatment
Thermal Pain Threshold Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
at 40 min. post-treatment
Baseline Nerve Conduction Latency
Time Frame: Baseline at 0 min.
The compound action potential latencies will be measured and will be expressed in ms.
Baseline at 0 min.
Nerve Conduction Latency Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
The compound action potential latencies will be measured and will be expressed in ms.
at 20 min. post-treatment
Nerve Conduction Latency Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
The compound action potential latencies will be measured and will be expressed in ms.
at 40 min. post-treatment
Baseline Tactile Threshold
Time Frame: Baseline at 0 min.
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
Baseline at 0 min.
Tactile Threshold Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
at 20 min. post-treatment
Tactile Threshold Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
at 40 min. post-treatment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin Temperature
Time Frame: Baseline, during treatment at 15 min., immediately after treatment at 20 min., at 20 min. post-treatment, at 40 min. post-treatment
Skin temperature (ºC) will be recorded in all assessment times.
Baseline, during treatment at 15 min., immediately after treatment at 20 min., at 20 min. post-treatment, at 40 min. post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juan Avendaño-Coy, MsC, University of Castilla-La Mancha, Toledo, Spain

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

November 18, 2014

First Submitted That Met QC Criteria

December 15, 2014

First Posted (Estimate)

December 19, 2014

Study Record Updates

Last Update Posted (Actual)

July 31, 2017

Last Update Submitted That Met QC Criteria

July 3, 2017

Last Verified

July 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on 5 KHz

Subscribe